# Identification of Polymorphisms Involved in the Metabolism of Propofol

> **NCT02271542** · PHASE4 · COMPLETED · sponsor: **TC Erciyes University** · enrollment: 300 (actual)

## Conditions studied

- UGT1A1*28 Polymorphism

## Interventions

- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT02271542
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271542, "Identification of Polymorphisms Involved in the Metabolism of Propofol". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02271542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
